Johnson & Johnson just announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate where it will look to enroll up to 60,000 volunteers across three continents.
Latest market news
Yesterday 03:00 PM
Yesterday 01:12 PM
Yesterday 11:14 AM
Yesterday 08:28 AM
April 24, 2024 03:30 PM